Duguay A B, Yousef I M, Plaa G L
Départment de pharmacologie, Faculté de médecine, Université de Montréal, Québec, Canada.
Toxicol Sci. 2000 Jan;53(1):150-5. doi: 10.1093/toxsci/53.1.150.
Manganese-bilirubin (Mn-BR)-induced cholestasis in rats is associated with altered lipid composition of various hepatic subcellular fractions. Increased bile canalicular (BCM) cholesterol content in Mn-BR cholestasis and the intracellular source of the accumulating cholesterol were investigated. To label the total hepatic cholesterol pool, male Sprague-Dawley rats were given ip 3H-cholesterol, followed 18 h later by 2-14C-mevalonic acid (a precursor of cholesterol synthesis). To induce cholestasis, manganese (Mn, 4.5 mg/kg) and bilirubin (BR, 25 mg/kg) were injected iv; animals were killed 30 min after BR injection; canalicular and sinusoidal membranes, microsomes, mitochondria, and cytosol were isolated. Total cholesterol content of each fraction was determined by spectrophotometric techniques as well as radiolabeled techniques. In Mn-BR cholestasis, the total cholesterol concentrations of BCM and cytosol were significantly increased. Also, the contribution of 14C-labeled cholesterol (newly synthesized cholesterol) was enhanced in all isolated cellular fractions. The results are consistent with the hypothesis that accumulation of newly synthesized cholesterol in BCM is involved in Mn-BR cholestasis. An enhanced rate of synthesis of cholesterol, however, does not appear to be the causal event, as the activity of HMG-CoA reductase (rate-limiting enzyme in cholesterol synthesis), assessed in vitro, was decreased following Mn-BR treatment. Treatment with the Mn-BR combination may affect other aspects of intracellular cholesterol dynamics.
锰-胆红素(Mn-BR)诱导的大鼠胆汁淤积与各种肝亚细胞组分脂质组成的改变有关。研究了Mn-BR胆汁淤积时胆小管(BCM)胆固醇含量的增加以及蓄积胆固醇的细胞内来源。为标记肝脏总胆固醇池,给雄性Sprague-Dawley大鼠腹腔注射³H-胆固醇,18小时后注射²-¹⁴C-甲羟戊酸(胆固醇合成的前体)。为诱导胆汁淤积,静脉注射锰(Mn,4.5mg/kg)和胆红素(BR,25mg/kg);在注射BR后30分钟处死动物;分离胆小管和窦状隙膜、微粒体、线粒体和胞质溶胶。通过分光光度技术和放射性标记技术测定各组分的总胆固醇含量。在Mn-BR胆汁淤积中,BCM和胞质溶胶的总胆固醇浓度显著增加。此外,在所有分离的细胞组分中,¹⁴C标记胆固醇(新合成的胆固醇)的贡献均增强。结果与以下假设一致,即新合成的胆固醇在BCM中的蓄积参与了Mn-BR胆汁淤积。然而,胆固醇合成速率的提高似乎并非因果事件,因为体外评估的HMG-CoA还原酶(胆固醇合成中的限速酶)活性在Mn-BR处理后降低。Mn-BR联合处理可能会影响细胞内胆固醇动态的其他方面。